A. Vogel AG

A. Vogel AG logo
🇨🇭Switzerland
Ownership
Private
Established
1963-01-01
Employees
-
Market Cap
-
Website
http://www.avogel-company.ch

Mental Balance Study

First Posted Date
2023-03-07
Last Posted Date
2024-08-06
Lead Sponsor
A. Vogel AG
Target Recruit Count
36
Registration Number
NCT05757050
Locations
🇬🇧

Northumbria University, Newcastle Upon Tyne, Tyne & Wear, United Kingdom

Sleep Well Observation Study

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2023-02-28
Last Posted Date
2024-08-06
Lead Sponsor
A. Vogel AG
Target Recruit Count
50
Registration Number
NCT05748574
Locations
🇩🇪

daacro GmbH & Co. KG, Trier, Rheinland-Pfalz, Germany

Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections

First Posted Date
2021-08-12
Last Posted Date
2021-08-12
Lead Sponsor
A. Vogel AG
Target Recruit Count
122
Registration Number
NCT05002179
Locations
🇧🇬

Diagnostics and Consultation Center Convex EOOD, Sofia, Bulgaria

Echinaforce COVID-19 Shedding Study

First Posted Date
2021-08-10
Last Posted Date
2024-08-06
Lead Sponsor
A. Vogel AG
Target Recruit Count
40
Registration Number
NCT04999098
Locations
🇧🇬

Diagnostics and Consultation Center Convex EOOD, Sofia, Bulgaria

Study to Assess Safety and Efficacy of Nephrosolid Tbs to Stimulate Urinary Output in Non-patient Volunteers

Phase 3
Completed
Conditions
Interventions
First Posted Date
2020-04-08
Last Posted Date
2020-04-08
Lead Sponsor
A. Vogel AG
Target Recruit Count
66
Registration Number
NCT04338477
Locations
🇨🇭

Privat practice of Dr. med. Bruno Haug, Medizinisches Zentrum Arbon, Arbon, Thurgau, Switzerland

🇨🇭

Private Practice Dr. med Bernhard Waelti, Freidorf, Thurgau, Switzerland

Safety and Efficacy of the Sore Throat Lozenges to Treat Acute Sore Throats

First Posted Date
2019-10-25
Last Posted Date
2021-08-05
Lead Sponsor
A. Vogel AG
Target Recruit Count
74
Registration Number
NCT04139681
Locations
🇧🇬

Diagnostics and Consultation Center Convex EOOD, Sofia, Bulgaria

Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections

First Posted Date
2019-01-23
Last Posted Date
2021-05-04
Lead Sponsor
A. Vogel AG
Target Recruit Count
246
Registration Number
NCT03812900
Locations
🇨🇭

Cantonal Hospital St. Gallen, Saint Gallen, Switzerland

Echinaforce Junior Bioavailability Trial

Phase 4
Withdrawn
Conditions
Interventions
First Posted Date
2017-03-03
Last Posted Date
2018-07-18
Lead Sponsor
A. Vogel AG
Registration Number
NCT03070314
Locations
🇨🇭

University Children's Hospital (UZH-UCH), Infectiology, University of Zurich, Zurich, Switzerland

Echinacea Junior vs Vitamin C in Children 4-12 Years Old

Phase 3
Completed
Conditions
Interventions
First Posted Date
2016-11-23
Last Posted Date
2021-05-04
Lead Sponsor
A. Vogel AG
Target Recruit Count
203
Registration Number
NCT02971384
Locations
🇨🇭

Dr. med. Mercedes Ogal, Brunnen, Switzerland

Study of Echinaforce Junior Tablets in Children With Acute Colds

Completed
Conditions
First Posted Date
2014-07-23
Last Posted Date
2021-05-04
Lead Sponsor
A. Vogel AG
Target Recruit Count
79
Registration Number
NCT02198391
Locations
🇨🇭

Dr. med. Arnold Bächler Facharzt FMH für Kinder- und Jugendmedizin, St. Gallen, Saint Gallen, Switzerland

© Copyright 2024. All Rights Reserved by MedPath